Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's (NYSE: LLY) Zepbound delivering ...

Often likened to mermaids in media reports and popular culture, South Korea’s famed Haenyeo (“sea women”) spend much of the ...

The ASX has dipped amid reignited trade tensions. Meanwhile, investors chased gains in Bluescope, and in the Brickworks-Soul ...

The ASX slipped 0.24pc as falling oil prices hit Energy and Utilities sectors, while a lift in gold offered some small relief ...

Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 30, 2025 /PRNewswire/ -- The concept of AI in healthcare is no longer a novelty ...

The concept of AI in healthcare is no longer a novelty, experts are acknowledging AI algorithms, detection, and drug ...

Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.

I remember the first time I walked into a Raley's to buy gluten free food. It was 15 years ago and there were maybe half a ...

LOS ANGELES, CA / ACCESS Newswire / May 29, 2025 / Mitolyn has quickly become one of the hottest weight loss supplements in 2025. If you're like me, you've probably seen it all over social media, ...